Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost protection against the new variant later this year.

Booster shots of the Pfizer-BioNTech and Moderna vaccines have proven highly effective at preventing Omicron-related hospitalisations, according to three new studies by the US Centers for Disease ...

Moderna today said both versions of its updated booster shots against Omicron variants—one that targets BA.1 and the other geared toward BA.4/5—prompts a better antibody response than its original ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Moderna yesterday announced that it has submitted an application to the Food and Drug Administration (FDA) for emergency use of its bivalent (two-strain) COVID booster vaccine that targets the BA.4/BA ...

1 booster (and Moderna’s, though the TGA has not approved ... Most recently we’ve faced a soup of Omicron sub-variants, including JN.1. Since JN.1 was first detected in August 2023, this ...

Moderna Inc. said Thursday a Phase 3 trial of ... which showed that mRNA-1283 had higher neutralizing antibody responses against both Omicron BA.4/5 and ancestral SARS-CoV-2 than mRNA-1273 ...

Moderna says its updated coronavirus vaccine ... final approval to updated COVID-19 vaccines targeting the dominant omicron variant on Thursday. According to the White House's COVID-19 response ...

1 Omicron subvariant. The Omicron booster made by Pfizer Inc. can be administered to people 12 and older, while Moderna Inc.’s Omicron booster is authorized for those 18 and older. In the past ...

1 Omicron subvariant, which was prevalent last winter, and the original novel coronavirus strain that the previous vaccines were designed to fight. Pfizer Inc. and Moderna Inc. have each applied ...